Onishi M
Third Department of Internal Medicine, University of Tokyo, Japan.
Int J Hematol. 1998 Apr;67(3):221-7. doi: 10.1016/s0925-5710(98)00009-7.
Cytokine signal transduction pathways are highly redundant and complex. The analysis of the structure and function of signal transduction molecules was conventionally done by using mutated or truncated receptors, dominant negative molecules, and knockout mice. These methods are designed to look at the result of a subtraction of a part of the whole signal transduction pathway. In contrast, analysis using activating mutations of a signal transduction molecule is designed to look at the downstream result of one pathway which originated from the pertinent molecule. This method is less influenced by other signal transduction molecules which may have an overlapping effect on the downstream molecules. By combining both the subtraction and activating methods, we can gain more insight into the complex interactions between signal transduction molecules. An activating mutation of a signal transduction molecule is usually found as an oncogene. However, known oncogenes are not always the molecules of interest. In this review, several methods to create activating mutations of a target molecule are discussed.
细胞因子信号转导通路高度冗余且复杂。传统上,信号转导分子的结构和功能分析是通过使用突变或截短的受体、显性负性分子以及基因敲除小鼠来进行的。这些方法旨在观察整个信号转导通路中一部分被去除后的结果。相比之下,使用信号转导分子的激活突变进行分析旨在观察源自相关分子的一条通路的下游结果。该方法受其他可能对下游分子有重叠作用的信号转导分子的影响较小。通过结合减法和激活方法,我们可以更深入地了解信号转导分子之间复杂的相互作用。信号转导分子的激活突变通常作为癌基因被发现。然而,已知的癌基因并不总是我们感兴趣的分子。在本综述中,讨论了几种产生目标分子激活突变的方法。